David R. Bauer
Lawyers
Filters
Connect Biopharma $219.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Nurix Therapeutics $160.4 million follow-on offering
We advised the underwriters on the equity offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Adamas Pharmaceuticals $59 million stock offering
We advised the joint book-running managers on the SEC-registered equity offering
Evernorth acquisition of MDLIVE
We are advising MDLIVE on the transaction
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
Corvus Pharmaceuticals $34 million stock offering
We advised the underwriters on the equity offering
Biogen exchange offer
We advised the dealer managers on a debt exchange offer
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing